Vical Reports 2013 Financial Results and Progress in Key Development Programs – MarketWatch
Vical Reports 2013 Financial Results and Progress in Key Development ProgramsMarketWatchAstellas is conducting a multinational Phase 3 registration trial of ASP0113 in approximately 500 hematopoietic stem cell transplant (HCT) recipients. The 1:1 rando…